Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasser:Naumann, Patrick [VerfasserIn]   i
 Eberlein, Jonathan [VerfasserIn]   i
 Farnia, Benjamin [VerfasserIn]   i
 Liermann, Jakob [VerfasserIn]   i
 Hackert, Thilo [VerfasserIn]   i
 Debus, Jürgen [VerfasserIn]   i
 Combs, Stephanie E. [VerfasserIn]   i
Titel:Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation
Verf.angabe:Patrick Naumann, Jonathan Eberlein, Benjamin Farnia, Jakob Liermann, Thilo Hackert, Jürgen Debus and Stephanie E. Combs
E-Jahr:2019
Jahr:26 October 2019
Umfang:14 S.
Fussnoten:Gesehen am 23.12.2019
Titel Quelle:Enthalten in: Cancers
Ort Quelle:Basel : MDPI, 2009
Jahr Quelle:2019
Band/Heft Quelle:11(2019,11) Artikel-Nummer 1655, 17 Seiten
ISSN Quelle:2072-6694
Abstract:Background: Patients with pancreatic cancer often develop cancer cachexia, a complex multifactorial syndrome with weight loss, muscle wasting and adipose tissue depletion with systemic inflammation causing physical impairment. In patients with locally advanced pancreatic cancer (LAPC) neoadjuvant treatment is routinely performed to allow a subsequent resection. Herein, we assess body composition and laboratory markers for cancer cachexia both before and after neoadjuvant chemoradiation (CRT). Methods: Subcutaneous fat (SCF), visceral fat (VF), skeletal muscle (SM), weight and laboratory parameters were determined longitudinally in 141 LAPC patients treated with neoadjuvant CRT. Changes during CRT were statistically analyzed and correlated with outcome and Kaplan–Meier curves were plotted. Different prognostic factors linked to cachexia were assessed by uni- and multivariable cox proportional hazards models. Results: There was a significant decrease in weight as well as SCF, VF and SM during CRT. The laboratory parameter C-reactive protein (CRP) increased significantly, whereas there was a significant decrease in leukocyte count, hemoglobin, albumin and cholinesterase as well as in the tumor marker CA 19.9. Cachectic weight loss, sarcopenia, reductions in body compartments SCF, VF and SM, and changes in laboratory markers as well as resection affected survival in univariable analysis. In multivariable analysis, weight loss >5% (HR 2.8), reduction in SM >5% (HR 5.5), an increase in CRP (HR 2.2) or CA 19.9 (HR 1.9), and resection (HR 0.4) remained independently associated with survival, whereas classical cachexia and sarcopenia did not. Interestingly, the subgroup of patients with cachectic weight loss >5% or SM reduction >5% during CRT did not benefit from resection (median survival 12 vs. 27 months). Conclusions: Persistent weight loss and muscle depletion during CRT as well as systemic inflammation after CRT impacted survival more than cachexia or sarcopenia according classical definitions.
DOI:doi:10.3390/cancers11111655
URL:Kostenfrei: Volltext ; Verlag: https://doi.org/10.3390/cancers11111655
 Kostenfrei: Volltext: https://www.mdpi.com/2072-6694/11/11/1655
 DOI: 10.3390/cancers11111655
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:adipose tissue
 body composition
 cachexia
 chemoradiation
 locally advanced pancreatic cancer
 muscle wasting
 sarcopenia
 skeletal muscle index
 weight loss
K10plus-PPN:1686331487
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68470483   QR-Code
zum Seitenanfang